AGER and type 2 diabetes mellitus: Mice with type 1 (streptozotocin) and type 2 diabetes (db/db mice) were immunized through three rounds of injections; for up to 38 weeks, the evidence of the immunization was apparent through analysis of anti-RAGE antibody titers [79].